What is LOPJLB’s current signal on CRBU?

LOPJLB’s latest quantitative signal on Caribou Biosciences, Inc. (CRBU) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CRBU in?

Caribou Biosciences, Inc. (CRBU) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Caribou Biosciences, Inc. based / listed?

Caribou Biosciences, Inc. is based in US, listed on NASDAQ.

Caribou Biosciences, Inc. (CRBU)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.46-4.17%Close

SELLCRISIS · day 23

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $46M
Beta: 2.31
P/E (TTM): -1.05

Short % float: 14.42%
Days to cover: 13.1
SI change: -0.5%

1W: -62.30%
1M: -66.42%

vs SPY 1W: -63.46%
vs SPY 1M: -69.42%

Industry peers

FMP comparable companies · ranked by market cap

ALLOSELLAllogene Therapeutics, Inc.$504MCRISISQ -12$1.46+4.29%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving…

Employees: 97
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 99.2M
Float: 90.3%

cariboubio.com ↗

Key executives

Rachel E. Haurwitz — Co-Founder, Chief Executive Officer, President & Director

Timothy Kelly — Chief Technology Officer

Barbara G. McClung — Chief Legal Officer & Corporate Secretary

SEC filings

EDGAR · CIK 16198560 · CRBU

Analyst consensus

Buy

Bullish660.0%

Neutral440.0%

Bearish00.0%

L $1.00Avg $1.00H $1.00

Target$1.00+117.39%

Last$0.46

Key stats

Industry peers

Prediction markets

Company news